cystamine has been researched along with Disease Exacerbation in 3 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Cystamine can ameliorate CCl(4) induced liver fibrosis and protect hepatic function." | 1.34 | Cystamine ameliorates liver fibrosis induced by carbon tetrachloride via inhibition of tissue transglutaminase. ( Chen, W; Qiu, JF; Wu, ZY; Zhang, ZQ, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fox, JH | 1 |
| Barber, DS | 1 |
| Singh, B | 1 |
| Zucker, B | 1 |
| Swindell, MK | 1 |
| Norflus, F | 1 |
| Buzescu, R | 1 |
| Chopra, R | 1 |
| Ferrante, RJ | 1 |
| Kazantsev, A | 1 |
| Hersch, SM | 1 |
| Bailey, CD | 1 |
| Johnson, GV | 1 |
| Qiu, JF | 1 |
| Zhang, ZQ | 1 |
| Chen, W | 1 |
| Wu, ZY | 1 |
3 other studies available for cystamine and Disease Exacerbation
| Article | Year |
|---|---|
Cystamine increases L-cysteine levels in Huntington's disease transgenic mouse brain and in a PC12 model of polyglutamine aggregation.
Topics: Animals; Antioxidants; Brain; Buthionine Sulfoximine; Cystamine; Cysteine; Cytoprotection; Disease M | 2004 |
The protective effects of cystamine in the R6/2 Huntington's disease mouse involve mechanisms other than the inhibition of tissue transglutaminase.
Topics: Age Factors; Age of Onset; Animals; Body Weight; Cystamine; Disease Models, Animal; Disease Progress | 2006 |
Cystamine ameliorates liver fibrosis induced by carbon tetrachloride via inhibition of tissue transglutaminase.
Topics: Actins; Animals; Carbon Tetrachloride; Collagen; Cystamine; Disease Progression; Enzyme Inhibitors; | 2007 |